NYSE:MYOV
Myovant Sciences Ltd.
- Stock
locale
United Kingdommarket
STOCKSindustry
Biotechnologywebsite
myovant.comipo date
Oct 27, 2016
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. I...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus